INVEST IN THE FIGHT TO END BREAST CANCER FOREVER.
It’s Everyone’s Race!
What is it all about?
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure® and launched the global breast cancer movement. Today, Komen for the Cure is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Since its funding in 1982, Komen has funded more than $800 million in research and provided more than $2.2 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. Komen was founded by Nancy Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life. Visit www.komen.org or call 1-877 GO KOMEN.
“I know firsthand the impact of Komen's research in advancing our knowledge to reduce death rates and improve treatment and survivability of this disease. I've seen the value of Komen's community health programs in the U.S., and I understand the urgency and promise of our global outreach and advocacy work.”
Judy Salerno, M.D., M.S., President and CEO of Susan G. Komen®
Local presenting sponsor, the Barbara Ann Karmanos Cancer Institute is committed to a future free of cancer. As Michigan’s only hospital solely dedicated to treating cancer, and the most preferred hospital for cancer care in Southeast Michigan, the Karmanos Cancer Institute is one of 41 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for 6,000 new patients annually on a budget of $260 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, Karmanos is among the nation’s best cancer centers. Through the commitment of more than 1,000 staff, including nearly 300 physicians and researchers on faculty at the Wayne State University School of Medicine, and supported by thousands of volunteers and financial donors, Karmanos strives to prevent, detect and eradicate all forms of cancer. It's long-term partnership with the WSU School of Medicine enhances the collaboration of critical research and academics related to cancer care. The Institute was named in 1995 in memory of Barbara Ann Karmanos, wife of Compuware cofounder Peter Karmanos, Jr. Barbara Ann was 46 when she died from breast cancer. For more information, visit www.karmanos.org or call (800) KARMANOS.
“Hope is on the horizon at Karmanos where we push forward with research. You can count on us to stay on the forefront of this battle. We are committed to do everything we can to achieve our goal of a future free of cancer.”
Gerold Bepler, M.D., Ph.D., President and CEO of Barbara Ann Karmanos Cancer Institute